casdatifan
ARC-20
Phase 1 small_molecule active
Quick answer
casdatifan for Clear Cell Renal Cell Carcinoma is a Phase 1 program (small_molecule) at Arcus Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arcus Biosciences
- Indication
- Clear Cell Renal Cell Carcinoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active